Effects of Fatty Acid Supplementation on Substance Dependent Individuals

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 2004

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Substance-related Disorders

Interventions

DRUG

Pro-eicosapentaenoic acid (EPA)

450 mg 5x/day

DRUG

Pro-docosapentaenoic acid (DPA)

100mg 5x/day

DRUG

Placebo

5 capsules/day

All Listed Sponsors

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00312455 - Effects of Fatty Acid Supplementation on Substance Dependent Individuals | Biotech Hunter | Biotech Hunter